On-Demand ICS + FABA Combinations in 6–11-Year-Old Children
In recent years, some new concepts have been added to asthma treatment such as “anti-inflammatory reliever” (β2-agonist use associated to an inhaled corticosteroid (ICS) as a reliever treatment) that combines the benefits of both therapies and provides short- and long-term benefits for treatment in...
Main Authors: | Elsy M. Navarrete-Rodríguez, Blanca E. Del-Rio-Navarro, Désirée Larenas-Linnemann, Jose A. Castro-Rodriguez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/23/7270 |
Similar Items
-
Clarifying SABA overuse: Translating Canadian Thoracic Society guidelines into clinical practice
by: Anne K. Ellis, et al.
Published: (2022-06-01) -
ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy
by: Álvaro A. Cruz, et al.
Published: (2021-01-01) -
Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma
by: Richard Beasley, et al.
Published: (2019-12-01) -
Maintenance Therapy for Children and Adolescents with Asthma: Guidelines and Recommendations from the Emilia-Romagna Asthma (ERA) Study Group
by: Valentina Fainardi, et al.
Published: (2023-08-01) -
The use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics
by: Benfante A, et al.
Published: (2016-10-01)